Attenuation of myocardial stunning in isolated rat hearts by a 21- aminosteroid lazaroid (U74389g)

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 5, 1996, Pages 659-664

  Moreyra, Abel E ^a   Conway, Robert S ^a   Wilson, Alan C ^a   Chen, Wen H ^a   Schmidling, Michael J ^a   Kostis, John B ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Lazaroid; Lipid peroxidation; Myocardial reperfusion; Stunning; U74389G

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; LAZAROID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART FUNCTION; HEART MUSCLE REPERFUSION; INTRAARTERIAL DRUG ADMINISTRATION; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STUNNED HEART MUSCLE;

ANIMALS; ANTIOXIDANTS; HEART; MALE; MYOCARDIAL REPERFUSION; MYOCARDIAL STUNNING; PREGNATRIENES; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR PRESSURE;

EID: 0029857177     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199611000-00008     Document Type: Article

References (24)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation 1982;66: 1146-9.
2. Levitt MA, Sievers RE, Wolfe CL. Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A, a nonglucocorticoid 21-aminosteroid. J Cardiovasc Pharmacol 1994; 23:136-40.
3. Jeroudi MO, Cheirif J, Habib G, Bolli R. Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: a possible manifestation of myocardial stunning. Am Heart J 1994;127:1241-50.
4. Bolli R, Hartley CJ, Rabinovitz RS. Clinical relevance of myocardial "stunning." Cardiovasc Drugs Ther 1991;5:877-90.
5. Mazer CD. Stunned myocardium in warm and cold cardiac surgery. J Cardiac Surg 1994;9:503-5.
6. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987;262:10438-40.
7. Braughler JM, Pregenzer JF. The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals. Free Radic Biol Med 1989;7:125-30.
8. Balla G, Vercellotti GM, Eaton JW, Jacob HS. Iron loading of endothelial cells augments oxidant damage. J Lab Clin Med 1990;116: 546-54.
9. Natale JE, Schott RJ, Hall ED, Braughler JM, D'Alecy G. Effect of the aminosteroid U74006F after cardiopulmonary arrest in dogs. Stroke 1988;19:1371-8.
10. Holzgrefe HH, Buchanan LV, Gibson JK. Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium. J Cardiovasc Pharmacol 1990;15:239-48.
11. Godin DV, Garnett ME, Ko KM. Effects of a steroidal antioxidant (U74006F) in an acute model of myocardial ischemia/reperfusion injury. Proc West Pharmacol Soc 1990;33:189-92.
12. Carrea FP, Lesnefsky EJ, Kaiser DG, Horwitz LD. The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion. J Cardiovasc Pharmacol 1992;20:230-5.
13. Kong Y, Lesnefsky EJ, Ye J, Horwitz LD. Prevention of lipid peroxidation does not prevent oxidant-induced myocardial contractile dysfunction. Am J Physiol 1994;267;H2371-7.
14. Weiss JL, Frederickson JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976;58:751-60.
15. Simari RD, Bell MR, Schwartz RS, Nishimura RA, Holmes DR Jr. Ventricular relaxation and myocardial ischemia: a comparison of different models of tau during coronary angioplasty Cathet Cardiovasc Diagn 1992;25:278-84.
16. Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill, 1971:514-5.
17. Weiss RG, Kalil-Filho R, Herskowitz A, et al. Tricarboxylic acid cycle activity in postischemic rat hearts. Circulation 1993;87: 270-82.
18. Correti M, Koretsune Y, Kusuoka H, Chacko VP, Zweier J, Marban E. Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts. J Clin Invest 1991;88:1014-25.
19. Magni F, Panduri G, Paolocci N. Hypothermia triggers lipoperoxidative damage in the isolated rat heart. Free Radic Biol Med 1994; 16:465-76.
20. Soufer R, Sinusas AJ, Zoghbi S, Zaret BL. The limitation of myocardial reperfusion injury with the 21-aminosteroid U74006F. Circulation 1990;82(suppl III):III-37.
21. Killinger WA, Dorofi DB, Keagy BA, Johnson G Jr. Improvement of endothelial cell viability at 4°C by addition of lazaroid U74500A to preservation solutions. Transplantation 1992;53:983-6.
22. Hendry PJ, Anstadt MP, Plunkett MD, Amato MT, Menius JA Jr, Lowe JE. Improved donor myocardial recovery with a new lazaroid lipid antiperoxidant in the isolated canine heart. J Heart Lung Transplant 1992;11:636-45.
23. Ovize M, de Lorgeril M, Ovize A, Ciavatti M, Delaye J, Renaud S. U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarction size in a canine model of myocardial ischemia reperfusion. Am Heart J 1991;122:681-9.
24. Singal PK, Dhalla AK, Hill M, Thomas TP. Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions. Mol Cell Biochem 1993;129:179-86.